UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of the Immune Microenvironment in Hepatocellular Carcinoma

Clinical cancer research, 2017-12, Vol.23 (23), p.7333-7339

2017

Volltextzugriff (PDF)

Immune checkpoint status in penile squamous cell carcinoma: A North American Cohort

Human pathology, 2017-01, Vol.59, p.55-61

2017

Volltextzugriff (PDF)

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma

The American journal of surgical pathology, 2007-08, Vol.31 (8), p.1246-1255

2007

Volltextzugriff (PDF)

Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma

The American journal of surgical pathology, 2010-03, Vol.34 (3), p.418-422

2010

Volltextzugriff (PDF)

Invariant NKT Cell Lines Derived from the NOD．H2^(h4) Mouse Enhance Autoimmune Thyroiditis

Journal of Thyroid Research, 2011, Vol.2011, p.895923-895923

2011

Volltextzugriff (PDF)

Animal models for autoimmune myocarditis and autoimmune thyroiditis

Methods in molecular medicine, 2004, Vol.102, p.175

2004

Volltextzugriff (PDF)

Invariant NKT Cell Lines Derived from the NOD⋅H2h4 Mouse Enhance Autoimmune Thyroiditis

Journal of thyroid research, 2011, Vol.2011 (2011), p.1-12

2011

Volltextzugriff (PDF)

Iodine and IFN-gamma synergistically enhance intercellular adhesion molecule 1 expression on NOD.H2h4 mouse thyrocytes

The Journal of immunology (1950), 2005-06, Vol.174 (12), p.7740-7745

2005

Volltextzugriff (PDF)

NKT Cell Regulation of Autoimmune Thyroiditis

Autoimmunity (Chur, Switzerland), 2003-09, Vol.36 (6-7), p.405-408

2003

Volltextzugriff (PDF)

The NOD.H2h4 mouse shows characteristics of human Sjogren’s Syndrome (130.26)

The Journal of immunology (1950), 2007-04, Vol.178 (1_Supplement), p.S232-S233

2007

Volltextzugriff (PDF)

Client incentives versus contracting and staff incentives: How care continuity interventions in substance abuse treatment can improve residential to outpatient transition

Journal of substance abuse treatment, 2013-07, Vol.45 (1), p.55-62

2013

Volltextzugriff (PDF)

Invariant NKT Cell Lines Derived from the NOD·H2 h4 Mouse Enhance Autoimmune Thyroiditis

Journal of thyroid research, 2011, Vol.2011, p.1-12

2011

Volltextzugriff (PDF)

Invariant NKT cell lines derived from the NODx[H2.sup.h4] mouse enhance autoimmune thyroiditis

Journal of thyroid research, 2011-01

2011

Volltextzugriff (PDF)

Iodine and IFN- gamma Synergistically Enhance Intercellular Adhesion Molecule 1 Expression on NOD.H2 super(h4) Mouse Thyrocytes

The Journal of immunology (1950), 2005-06, Vol.174 (12), p.7740-7745

2005

Volltextzugriff (PDF)

NKT cell regulation of autoimmune thyroiditis: Special Issue: Current Perspectives on Thyroid Autoimmune Diseases

Autoimmunity (Chur, Switzerland), 2003, Vol.36 (6-7), p.405-408

2003

Volltextzugriff (PDF)

Iodine and IFN-{gamma} Synergistically Enhance Intercellular Adhesion Molecule 1 Expression on NOD.H2h4 Mouse Thyrocytes

The Journal of immunology (1950), 2005-06, Vol.174 (12), p.7740

2005

Volltextzugriff (PDF)

Environmental Factors in Autoimmune Endocrinopathies

Autoimmune Diseases in Endocrinology, p.35-75

Volltextzugriff (PDF)

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

Human pathology, 2016-01, Vol.47 (1), p.52-63

2016

Volltextzugriff (PDF)

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

Human pathology, 2010, Vol.41 (1), p.20-25

2010

Volltextzugriff (PDF)

INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity

The American journal of surgical pathology, 2017-11, Vol.41 (11), p.1561-1569

2017

Volltextzugriff (PDF)

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

Human pathology, 2013-07, Vol.44 (7), p.1341-1349

2013

Volltextzugriff (PDF)

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas

Human pathology, 2013-06, Vol.44 (6), p.959-965

2013

Volltextzugriff (PDF)

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung

The American journal of surgical pathology, 2012-10, Vol.36 (10), p.1472-1476

2012

Volltextzugriff (PDF)

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non–small cell lung cancer

Human pathology, 2014-05, Vol.45 (5), p.926-934

2014

Volltextzugriff (PDF)

A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.197-8, Article 197

2019

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of the Immune Microenvironment in Hepatocellular Carcinoma

Immune checkpoint status in penile squamous cell carcinoma: A North American Cohort

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma

Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma

Invariant NKT Cell Lines Derived from the NOD．H2^(h4) Mouse Enhance Autoimmune Thyroiditis

Animal models for autoimmune myocarditis and autoimmune thyroiditis

Invariant NKT Cell Lines Derived from the NOD⋅H2h4 Mouse Enhance Autoimmune Thyroiditis

Iodine and IFN-gamma synergistically enhance intercellular adhesion molecule 1 expression on NOD.H2h4 mouse thyrocytes

NKT Cell Regulation of Autoimmune Thyroiditis

The NOD.H2h4 mouse shows characteristics of human Sjogren’s Syndrome (130.26)

Client incentives versus contracting and staff incentives: How care continuity interventions in substance abuse treatment can improve residential to outpatient transition

Invariant NKT Cell Lines Derived from the NOD·H2 h4 Mouse Enhance Autoimmune Thyroiditis

Invariant NKT cell lines derived from the NODx[H2.sup.h4] mouse enhance autoimmune thyroiditis

Iodine and IFN- gamma Synergistically Enhance Intercellular Adhesion Molecule 1 Expression on NOD.H2 super(h4) Mouse Thyrocytes

NKT cell regulation of autoimmune thyroiditis: Special Issue: Current Perspectives on Thyroid Autoimmune Diseases

Iodine and IFN-{gamma} Synergistically Enhance Intercellular Adhesion Molecule 1 Expression on NOD.H2h4 Mouse Thyrocytes

Environmental Factors in Autoimmune Endocrinopathies

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non–small cell lung cancer

A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses

Suchergebnisse filtern